Table 1_Association of d-dimer levels with in-hospital death and multi-vessel coronary artery disease in patients with non–ST-segment elevation acute coronary syndrome.pdf by Ning Zhang (23771)

“…The cutoff plasma d-dimer level was determined using the Youden index to predict in-hospital death in patients with NSTEACS, and the rates of in-hospital mortality and multi-vessel CAD (2-vessel + 3-vessel disease) were compared between patients with high (103 patients) and low d-dimer levels (700 patients).…”

Table 2_Sarcopenia as a prognostic marker in patients undergoing pancreaticoduodenectomy: an updated meta-analysis.docx by Jie He (132999)

“…Patients without sarcopenia exhibited better DFS and OS after PD than those with sarcopenia (DFS: HR = 2.28, 95% CI = 1.18–2.88, P < 0.001; OS: HR = 3.15, 95% CI = 2.49–3.98, P < 0.001).</p>Conclusion<p>A high proportion of patients presented with sarcopenia before undergoing PD. …”

Table 4_Sarcopenia as a prognostic marker in patients undergoing pancreaticoduodenectomy: an updated meta-analysis.docx by Jie He (132999)

“…Patients without sarcopenia exhibited better DFS and OS after PD than those with sarcopenia (DFS: HR = 2.28, 95% CI = 1.18–2.88, P < 0.001; OS: HR = 3.15, 95% CI = 2.49–3.98, P < 0.001).</p>Conclusion<p>A high proportion of patients presented with sarcopenia before undergoing PD. …”

Image 3_Sarcopenia as a prognostic marker in patients undergoing pancreaticoduodenectomy: an updated meta-analysis.tif by Jie He (132999)

“…Patients without sarcopenia exhibited better DFS and OS after PD than those with sarcopenia (DFS: HR = 2.28, 95% CI = 1.18–2.88, P < 0.001; OS: HR = 3.15, 95% CI = 2.49–3.98, P < 0.001).</p>Conclusion<p>A high proportion of patients presented with sarcopenia before undergoing PD. …”

Image 1_Sarcopenia as a prognostic marker in patients undergoing pancreaticoduodenectomy: an updated meta-analysis.tif by Jie He (132999)

“…Patients without sarcopenia exhibited better DFS and OS after PD than those with sarcopenia (DFS: HR = 2.28, 95% CI = 1.18–2.88, P < 0.001; OS: HR = 3.15, 95% CI = 2.49–3.98, P < 0.001).</p>Conclusion<p>A high proportion of patients presented with sarcopenia before undergoing PD. …”

Table 3_Sarcopenia as a prognostic marker in patients undergoing pancreaticoduodenectomy: an updated meta-analysis.docx by Jie He (132999)

“…Patients without sarcopenia exhibited better DFS and OS after PD than those with sarcopenia (DFS: HR = 2.28, 95% CI = 1.18–2.88, P < 0.001; OS: HR = 3.15, 95% CI = 2.49–3.98, P < 0.001).</p>Conclusion<p>A high proportion of patients presented with sarcopenia before undergoing PD. …”

Image 2_Sarcopenia as a prognostic marker in patients undergoing pancreaticoduodenectomy: an updated meta-analysis.tif by Jie He (132999)

“…Patients without sarcopenia exhibited better DFS and OS after PD than those with sarcopenia (DFS: HR = 2.28, 95% CI = 1.18–2.88, P < 0.001; OS: HR = 3.15, 95% CI = 2.49–3.98, P < 0.001).</p>Conclusion<p>A high proportion of patients presented with sarcopenia before undergoing PD. …”

Image 4_Sarcopenia as a prognostic marker in patients undergoing pancreaticoduodenectomy: an updated meta-analysis.tif by Jie He (132999)

“…Patients without sarcopenia exhibited better DFS and OS after PD than those with sarcopenia (DFS: HR = 2.28, 95% CI = 1.18–2.88, P < 0.001; OS: HR = 3.15, 95% CI = 2.49–3.98, P < 0.001).</p>Conclusion<p>A high proportion of patients presented with sarcopenia before undergoing PD. …”

Table 1_Sarcopenia as a prognostic marker in patients undergoing pancreaticoduodenectomy: an updated meta-analysis.docx by Jie He (132999)

“…Patients without sarcopenia exhibited better DFS and OS after PD than those with sarcopenia (DFS: HR = 2.28, 95% CI = 1.18–2.88, P < 0.001; OS: HR = 3.15, 95% CI = 2.49–3.98, P < 0.001).</p>Conclusion<p>A high proportion of patients presented with sarcopenia before undergoing PD. …”

Data Sheet 1_Association between the triglyceride glucose-waist circumference index and cardiovascular disease across different glycemic statuses among middle-aged and older Chines... by Yuyu Cui (18762383)

“…Its clinical application may facilitate early identification and precise stratification of high-risk individuals, thereby providing strong support for CVD prevention and targeted intervention strategies.…”

Data Sheet 1_Exploring the shared gene signatures and mechanism among three autoimmune diseases by bulk RNA sequencing integrated with single-cell RNA sequencing analysis.docx by Xiaofang Liu (398453)

“…Background<p>Emerging evidence underscores the comorbidity mechanisms among autoimmune diseases (AIDs), with innovative technologies such as single-cell RNA sequencing (scRNA-seq) significantly advancing the explorations in this field. …”

Image 1_Combined association of gait speed and processing speed on cardiometabolic disease mortality risk in the US older adults: a prospective cohort study from NHANES.jpeg by Hang Yang (577653)

“…The slow gait was significantly associated with increased risk of CMD mortality, while low processing speed was only significantly associated with increased all-cause mortality risk. …”

Table 1_Combined association of gait speed and processing speed on cardiometabolic disease mortality risk in the US older adults: a prospective cohort study from NHANES.docx by Hang Yang (577653)

“…The slow gait was significantly associated with increased risk of CMD mortality, while low processing speed was only significantly associated with increased all-cause mortality risk. …”

Baseline characteristics of study participants. by Julia König (6055049)

Injectable and Degradable Zwitterionic Cryogels as Cancer Vaccine Platforms to Prevent Cancer Recurrence after Surgery by Xinxin Luo (8960012)

“…Cancer has become a highly prevalent disease and poses serious threats to human health. …”

Table 1_Decision regret and long-term weight evolution following laparoscopic sleeve gastrectomy as bridge to kidney transplantation.docx by Xin Yu Yang (22345702)

Table 5_Decision regret and long-term weight evolution following laparoscopic sleeve gastrectomy as bridge to kidney transplantation.docx by Xin Yu Yang (22345702)

Table 2_Decision regret and long-term weight evolution following laparoscopic sleeve gastrectomy as bridge to kidney transplantation.docx by Xin Yu Yang (22345702)

Table 4_Decision regret and long-term weight evolution following laparoscopic sleeve gastrectomy as bridge to kidney transplantation.docx by Xin Yu Yang (22345702)

Table 3_Decision regret and long-term weight evolution following laparoscopic sleeve gastrectomy as bridge to kidney transplantation.docx by Xin Yu Yang (22345702)